Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver Disease

NCT00535145 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

121

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Schizoaffective Disorder
Psychotic Disorders

Interventions

DRUG: Treatment as usual (TAU), Paliperidone ER

Sponsor

Ortho-McNeil Janssen Scientific Affairs, LLC